Song Xiang, Xing Yue-Ming, Wu Wei, Cheng Guo-Hua, Xiao Feng, Jin Gang, Liu Ying, Zhao Xin
Department of Oncology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Exp Ther Med. 2017 May;13(5):2463-2467. doi: 10.3892/etm.2017.4262. Epub 2017 Mar 24.
The aim of the present study was to detect the expression of Krüppel-like factor 4 (KLF4) in breast cancer tissues and to evaluate the effect on the proliferation of breast cancer MDA-MB-231 cells. The expression of KLF4 protein in 239 breast cancer tissues and 40 paracancerous tissues were detected by an immunohistochemical assay, and its correlation with clinical pathological parameters was analyzed. A eukaryotic expression vector, pcDNA3.1-KLF4, was constructed by transient transfection of breast cancer MDA-MB-231 cells with liposomes (experimental group). The untransfected cells and those transfected with empty plasmid pcDNA3.1 were used as the blank and negative control groups, respectively. The expression of the KLF4 gene and protein in the three groups were detected by reverse transcription polymerase chain reaction and western blotting, respectively. Furthermore, the cell proliferative capacity was detected by an MTT assay. The positive expression rate of KLF4 protein in breast cancer tissues (39.0%, 93/239) was significantly lower than that of paracancerous tissues (77.5%, 31/40) (P<0.05). In addition, KLF4 protein expression in breast cancer tissues was correlated with pathological type, histological grade and lymphatic metastasis (P<0.05). KLF4 mRNA and protein were both expressed by the experimental group, but not by the two control groups. Meanwhile, the proliferative capacity of the experimental group was also significantly decreased. A significant decrease in the positive expression rate of KLF4 protein in breast cancer tissues was correlated with several clinical pathological parameters. In addition, transfection of the KLF4 gene inhibited the proliferation of breast cancer cells, suggesting that this gene is important in the onset and progression of this type of cancer.
本研究旨在检测乳腺癌组织中Krüppel样因子4(KLF4)的表达,并评估其对乳腺癌MDA-MB-231细胞增殖的影响。采用免疫组织化学法检测239例乳腺癌组织和40例癌旁组织中KLF4蛋白的表达,并分析其与临床病理参数的相关性。通过脂质体瞬时转染乳腺癌MDA-MB-231细胞构建真核表达载体pcDNA3.1-KLF4(实验组)。未转染细胞和转染空质粒pcDNA3.1的细胞分别作为空白对照组和阴性对照组。分别采用逆转录聚合酶链反应和蛋白质印迹法检测三组中KLF4基因和蛋白的表达。此外,通过MTT法检测细胞增殖能力。乳腺癌组织中KLF4蛋白的阳性表达率(39.0%,93/239)显著低于癌旁组织(77.5%,31/40)(P<0.05)。此外,乳腺癌组织中KLF4蛋白表达与病理类型、组织学分级和淋巴转移相关(P<0.05)。实验组表达KLF4 mRNA和蛋白,而两个对照组均未表达。同时,实验组的增殖能力也显著降低。乳腺癌组织中KLF4蛋白阳性表达率显著降低与多个临床病理参数相关。此外,KLF4基因转染抑制了乳腺癌细胞的增殖,提示该基因在这类癌症的发生和发展中具有重要作用。